INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/23/2026
Back to search
Official data from USPTO
360 HCP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
360 HCP
ST13
US500000079149276Class
1, 9, 42
Filing
79149276
Registration
4693878
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
02/24/2026
Trademark type
Word
Nice classes
1, 9, 42
Filing date
01/30/2014
Registration date
03/03/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2025
Last transaction
02/24/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Berlin, DE
Examiner
WEIGLE, KATHERINE CONNOLLY
Current location
Historical data usage
Holders and representatives
Holders
BioGenes GmbH
Representatives
Bruce S. Londa Norris McLaughlin P.A.
Technical classification
Nice Classes
Class 1Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and chemical preparations for industrial and scientific use; in-vitro diagnostic preparations used in sciencein particular for industrial and scientific use; chemical test kitsconsisting of immunological or marked antibodies and related reagents on serological and immunogenic basis and reagents therefor for quality control analysis of biological pharmaceutics for laboratory or research use; reagent kits comprised of reagents for scientific or research purposes for conducting the enzyme-linked immune adsorption test (ELISA) not for medical or veterinary purposes; chemical preparations for scientific purposes in form of bufferssaltssolvents and reactants for the afore-mentioned test kits; chemical reagents for non-medical purposes for buffer solutions used in assay kits; antibody solutions and conjugates and derivatives made from thembiochemical for in vitro and in vivo scientific use; biochemical reagents for use in laboratories ; chemicalbiochemical or biological preparations and chemical reagents and kits made thereof for the detection of cancer conditionsneoplastic conditionsinflammation conditionsinfection conditionsdegenerative conditionsgenetically abnormal or morbid conditionsproliferative abnormal or morbid conditionsvascular diseasespremalignant conditionsmalignant conditionscancer and congenital defectsall for scientific and research purposes
Class 9
Laboratory equipmentantibody-coated laboratory worktops and microtiter platesin particular for specifying cell type
Class 42
Services of a biologistchemistry or biochemistry servicesbiochemical research and developmentcustom design and development of biochemical assays; services of a bacteriologicalmolecular-biological or chemical laboratoryresearch and testing and scientific laboratory services; researchdevelopment and corresponding consultancy in the field of diagnosticsin particular product development of reagents and test kitsin particular on serological and immunogenic basis for the chemistrybiochemistrybacteriology and biotechnology fields; conducting scientific testing and analysis in the field of virus diagnostics for determining contaminations in the production of active substances; development of testing methods and test kits for the chemistrybiochemistrybacteriology and biotechnology fields; services in the field of technical and scientific supportsscientific testing of immunoassays for determining contaminations of biological active substances and related diagnostic services in the field of research related thereto; biotechnological servicesresearch and development in the biotechnology field; consultancy relating to chemical and pharmaceutical researchconsultancy relating to the development of diagnostic tests and procedures for the chemistrybiochemistrybacteriology and biotechnology fields
Publications
History of USPTO decisions and trademark events.
43 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/23/2025
71AG
REGISTERED-SEC.71 ACCEPTED
06/23/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2025
ES71
TEAS SECTION 71 RECEIVED
03/05/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/03/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/01/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/05/2022
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/05/2022
INPC
INVALIDATION PROCESSED
04/04/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/17/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/17/2021
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
03/17/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/16/2021
ES71
TEAS SECTION 71 RECEIVED
02/12/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/06/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/17/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/30/2015
FIMP
FINAL DISPOSITION PROCESSED
06/30/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/03/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2015
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2014
PUBO
PUBLISHED FOR OPPOSITION
12/16/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/03/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/03/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/26/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/10/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2014
ALIE
ASSIGNED TO LIE
10/27/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2014
RFNT
REFUSAL PROCESSED BY IB
08/22/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/01/2014
RFRR
REFUSAL PROCESSED BY MPU
08/01/2014
MAFR
APPLICATION FILING RECEIPT MAILED
08/01/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/31/2014
CNRT
NON-FINAL ACTION WRITTEN
07/30/2014
DOCK
ASSIGNED TO EXAMINER
07/28/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/21/2014
Continuous trademark protection
Get notified about every new filing that threatens 360 HCP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.